Characteristics of participants with virological failure at month 12.
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://figshare.com/articles/dataset/_Characteristics_of_participants_with_virological_failure_at_month_12_/769378
下载链接
链接失效反馈官方服务：
资源简介：
A98G reduces NVP susceptibility, Y181C causes high-level resistance to NVP, G190A causes high level resistance to NVP and intermediate resistance to EFV, M184V cause high-level in vitro resistance to 3TC, K103N causes high-level resistance to NVP, and EFV, D67N, K70R and K219Q cause resistance to AZT and d4T.
*These participants showed mutations at baseline (see table 2).
**Participant sample failed sequencing at baseline.
NA- Not applicable since these samples failed to sequence at both baseline and month 12.
The drugs in bold and underlined have a reduced sensitivity against the mutated viruses.
创建时间：
2013-08-12
